Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case–control study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case–control study
Authors
Keywords
3–10 words: Sept9, Colorectal cancer, Screening, DNA methylation marker, Comorbidities, Epigenetics
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-29
DOI
10.1186/s12885-015-1832-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetics and Metabolism
- (2015) S. T. Keating et al. CIRCULATION RESEARCH
- DNA Methylome Signature in Synoviocytes From Patients With Early Rheumatoid Arthritis Compared to Synoviocytes From Patients With Longstanding Rheumatoid Arthritis
- (2015) Rizi Ai et al. Arthritis & Rheumatology
- Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future
- (2014) Yuemin Li et al. Biomarkers in Medicine
- Validation of a Real-Time PCR-Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human Plasma
- (2014) N. T. Potter et al. CLINICAL CHEMISTRY
- Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA
- (2014) Kinga Tóth et al. PLoS One
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island
- (2013) Reinhold Wasserkort et al. BMC CANCER
- Colorectal Cancer Screening with Blood-Based Biomarkers: Cost-Effectiveness of Methylated Septin 9 DNA versus Current Strategies
- (2013) U. Ladabaum et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- Blood-Based Testing for Colorectal Cancer Screening
- (2013) Karen A. Heichman Molecular Diagnosis & Therapy
- Survival outcome of patients with screening versus symptomatically detected colorectal cancers
- (2012) R. Pande et al. Colorectal Disease
- Epigenetic Modifications
- (2011) Diane E. Handy et al. CIRCULATION
- The Stool DNA Test Is More Accurate Than the Plasma Septin 9 Test in Detecting Colorectal Neoplasia
- (2011) David A. Ahlquist et al. Clinical Gastroenterology and Hepatology
- SEPT9_i1 and genomic instability: Mechanistic insights and relevance to tumorigenesis
- (2011) Esther A. Peterson et al. GENES CHROMOSOMES & CANCER
- Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren’s syndrome
- (2011) E Bartoloni et al. LUPUS
- Screening for colorectal cancer: possible improvements by risk assessment evaluation?
- (2011) Hans J. Nielsen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
- (2009) T. deVos et al. CLINICAL CHEMISTRY
- Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
- (2008) Robert Grützmann et al. PLoS One
- DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
- (2007) C. Lofton-Day et al. CLINICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More